294 related articles for article (PubMed ID: 12122483)
1. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
Smith MA; French AM
Psychopharmacology (Berl); 2002 Jul; 162(3):255-64. PubMed ID: 12122483
[TBL] [Abstract][Full Text] [Related]
2. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
Negus SS; Mello NK
Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
[TBL] [Abstract][Full Text] [Related]
3. Sex and rat strain determine sensitivity to kappa opioid-induced antinociception.
Barrett AC; Cook CD; Terner JM; Roach EL; Syvanthong C; Picker MJ
Psychopharmacology (Berl); 2002 Mar; 160(2):170-81. PubMed ID: 11875635
[TBL] [Abstract][Full Text] [Related]
4. Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement.
Negus SS; Mello NK
J Pharmacol Exp Ther; 1999 Sep; 290(3):1132-40. PubMed ID: 10454487
[TBL] [Abstract][Full Text] [Related]
5. Age-related differences in sensitivity to the antinociceptive effects of opioids in male rats. Influence of nociceptive intensity and intrinsic efficacy at the mu receptor.
Smith MA; Gray JD
Psychopharmacology (Berl); 2001 Aug; 156(4):445-53. PubMed ID: 11498722
[TBL] [Abstract][Full Text] [Related]
6. Enhanced sensitivity to the antinociceptive effects of kappa opioids in naltrexone-treated rats: dose- and time-dependent effects.
Smith MA; McClean JM; Greene JL
Behav Pharmacol; 2003 Dec; 14(8):641-7. PubMed ID: 14665981
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive effects of opioids following acute and chronic administration of butorphanol: influence of stimulus intensity and relative efficacy at the mu receptor.
Smith MA; Barrett AC; Picker MJ
Psychopharmacology (Berl); 1999 Apr; 143(3):261-9. PubMed ID: 10353428
[TBL] [Abstract][Full Text] [Related]
8. Effects of the long-lasting kappa opioid 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl) ethyl] acetamide in a drug discrimination and warm water tail-withdrawal procedure.
Terner JM; Lomas LM; Lewis JW; Husbands SM; Picker MJ
Behav Pharmacol; 2005 Dec; 16(8):665-70. PubMed ID: 16286819
[TBL] [Abstract][Full Text] [Related]
9. Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse.
Horan PJ; de Costa BR; Rice K; Haaseth RC; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Aug; 266(2):926-33. PubMed ID: 8394923
[TBL] [Abstract][Full Text] [Related]
10. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor.
Cook CD; Barrett AC; Roach EL; Bowman JR; Picker MJ
Psychopharmacology (Berl); 2000 Jul; 150(4):430-42. PubMed ID: 10958085
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.
Lomas LM; Barrett AC; Terner JM; Lysle DT; Picker MJ
Psychopharmacology (Berl); 2007 Apr; 191(2):273-85. PubMed ID: 17225166
[TBL] [Abstract][Full Text] [Related]
12. Long-term voluntary access to running wheels decreases kappa-opioid antinociception.
D'Anci KE; Gerstein AV; Kanarek RB
Pharmacol Biochem Behav; 2000 Jun; 66(2):343-6. PubMed ID: 10880688
[TBL] [Abstract][Full Text] [Related]
13. Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats.
Terner JM; Barrett AC; Grossell E; Picker MJ
Psychopharmacology (Berl); 2002 Sep; 163(2):183-93. PubMed ID: 12202965
[TBL] [Abstract][Full Text] [Related]
14. Dextromethorphan differentially affects opioid antinociception in rats.
Chen SL; Huang EY; Chow LH; Tao PL
Br J Pharmacol; 2005 Feb; 144(3):400-4. PubMed ID: 15655510
[TBL] [Abstract][Full Text] [Related]
15. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
[TBL] [Abstract][Full Text] [Related]
17. Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats.
Barrett AC; Smith ES; Picker MJ
Eur J Pharmacol; 2002 Oct; 452(2):163-73. PubMed ID: 12354566
[TBL] [Abstract][Full Text] [Related]
18. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
Craft RM; McNiel DM
Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
[TBL] [Abstract][Full Text] [Related]
19. An examination of the interactions between the antinociceptive effects of morphine and various mu-opioids: the role of intrinsic efficacy and stimulus intensity.
Morgan D; Cook CD; Smith MA; Picker MJ
Anesth Analg; 1999 Feb; 88(2):407-13. PubMed ID: 9972766
[TBL] [Abstract][Full Text] [Related]
20. Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.
Stevenson GW; Folk JE; Linsenmayer DC; Rice KC; Negus SS
J Pharmacol Exp Ther; 2003 Dec; 307(3):1054-64. PubMed ID: 14557380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]